ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPTI Optibiotix Health Plc

16.00
0.25 (1.59%)
26 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 1.59% 16.00 15.50 16.50 16.00 15.75 15.75 282,805 08:09:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.63 14.59M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 15.75p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £14.59 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.63.

Optibiotix Health Share Discussion Threads

Showing 20051 to 20074 of 147800 messages
Chat Pages: Latest  812  811  810  809  808  807  806  805  804  803  802  801  Older
DateSubjectAuthorDiscuss
25/1/2017
11:54
Scotty, true.
rafboy
25/1/2017
10:35
rafboy "I do find diamond to be interesting" i don't know if "interesting"is the right term of phrase i'd use for diamond.He keeps coming out with these one liners but unfortunately he cannot back them up.
scotty1
25/1/2017
10:29
Someuwin, thanks for sharing as you do. I take note of research and what the company has to say but I do find diamond to be interesting. I hope his predictions come true but OPTI will prove a winner either way. I have not been so relaxed about holding an Aim company for a long while.
rafboy
25/1/2017
10:27
Diamond... ur a geezer!!
nicktopten
25/1/2017
10:22
I very much like the phrase "a wide range of food products".

You can see why multiple global players want in on the OPTI action.


"...These ingredients are heat resistant and stable during processing, which creates the opportunity to incorporate low cost, safe, ingredients which modulate specific elements of the microbiome in a wide range of food products."

someuwin
25/1/2017
10:16
A few patents isn't going to blow my socks off! Are you hoping for some other news?
rafboy
25/1/2017
10:00
Get ready, not long now, get ready to have your socks blown off.
diamond fibre
25/1/2017
09:56
someuwin, thank you for sharing your response from SOH.
bobbyshilling
25/1/2017
09:43
Parob,
That's my thinking too, you don't put yourself in the spotlight at these conferences if you can't back it up with science and you certainly don't attend if your science is still floundering...you'd be made a laughing stock in the sector. These sort of conferences, IMHO, are the trend setters, where the science IS heading, the cutting edge...
All indicators are looking excellent so it's just a matter of time.

joyjoy13
25/1/2017
09:34
You are welcome joyjoy13. Whilst a 27% cholesterol reduction was mentioned, I'm wondering if that's on average and the reduction is much higher in higher risk groups as per April 2016 cholesterol results RNS.Knowing SOH is frugal, and knowing that sponsoring these congresses isn't cheap again makes me think that decent revenues (outside of gofigure) must be close.
parob
25/1/2017
09:26
Someuwin & Parob
Thank you for sharing the emails and your in depth research above, truly appreciated.

joyjoy13
25/1/2017
09:10
Good morning diamond ;0)
More patents: interesting - whilst it is a reasonable assumption that there will be more 'over time', you seem to be saying they are imminent.

You're putting your credibility on the line here I feel, but having said that, all to the good if proven correct.

Best wishes - Mike

spike_1
25/1/2017
09:10
This co has made massive progress in the last year. But you can still buy cheaper now than a year ago.

Best be quick though - imo.

someuwin
25/1/2017
09:08
Well that dip was soon bought into and reversed.....now back to the rising trend!
parob
25/1/2017
08:58
diamond yuo relly oght to raed wat yuo hve witten and ave a spelceck bfore postin :)
scotty1
25/1/2017
08:50
Diamond, do you mean patents?
rafboy
25/1/2017
08:44
More paitences coming.
diamond fibre
25/1/2017
08:05
Over 80p by end of the week imo.
someuwin
25/1/2017
07:55
From the proactive article yesterday:"With the microbiome fast becoming a rapidly growing area of interest, OptiBiotix is well positioned to be one of the leaders in this field," claims finnCap's Alex Pye.
parob
25/1/2017
07:52
From the link in SOH email yesterday...

Cleveland Clinic Unveils Top 10 Medical Innovations Most Likley To Be Game Changers
A panel of top doctors and researchers presents the advancements with the power to transform healthcare in 2017
October 26, 2016

Topping the 11th annual list is the harnessing of the microbiome, the gut bacteria swarming in all of us. Recent discoveries have revealed the power of microbes to prevent, diagnose and treat disease. The healthcare industry will soon be pouring resources into addressing the potential for new therapies, diagnostics, probiotics and other products.

1. Using the Microbiome to Prevent, Diagnose and Treat Disease

When it comes to life-saving potential and market opportunities, the gut is a gold mine. Trillions of bacteria making up communities in our body – the microbiome – are unlocking mysteries at a rapid pace as the market scrambles to address the possibilities.

The crux of the discovery, made within the last 10 years, is that our microbes have a mind of their own. The chemicals they emit interfere with the way food is digested, medicine is deployed, and even how a disease progresses.

Biotech companies once focused on the genomic market are pivoting to the potential of the microbiome to develop new diagnostics, new therapies, and “probioticR21; products to prevent dangerous microbe imbalances.

With the National Microbiome Initiative accelerating research and development, experts believe 2017 is the year the microbiome cements itself as the healthcare industry’s most promising and lucrative frontier.

someuwin
25/1/2017
07:44
Looking at the end of day trading we need some buyers this morning to stop the weak taking control again
Have some dry gunpowder if it does happen to go to far down

judijudi
25/1/2017
01:23
The sales near the end of day do not suggest the quick sell off shown. It shows how a few small moves can widen prices. It will be interesting if there is a reversal in the morning.Note to john henry. You are close to where I live, in the fourth most expensive city in the world. It does not feel like I live in a one million pound house and I will not be taking the money, just yet!
aspex
25/1/2017
00:57
Great stuff - someuwin & Parob,

JH - don't you put that ring on...they will hunt you down!

elrico
24/1/2017
20:40
someuwin,
indeed brilliant. Means much more to me than the dry RNS this morning.!

Best wishes - Mike

spike_1
Chat Pages: Latest  812  811  810  809  808  807  806  805  804  803  802  801  Older

Your Recent History

Delayed Upgrade Clock